Konstantin Poukalov - Jun 21, 2023 Form 4 Insider Report for LianBio (LIAN)

Role
Director
Signature
/s/ Angela Chen, Attorney-in-Fact
Stock symbol
LIAN
Transactions as of
Jun 21, 2023
Transactions value $
$0
Form type
4
Date filed
6/23/2023, 04:10 PM
Previous filing
Jun 27, 2022
Next filing
Jul 5, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option shall vest and become exercisable in full on June 21, 2024, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date.